Don't rain on Anitbotters parade Miso..
Pharmasset's market cap in 2007 was $364M. It took one or two non commercialized late stage molecules to propel it to $11 billion 5 years later.
Maybe our HRV/RSV combo will do the trick in a couple of years time. Or the HCV drug if we keep it away from Biocryst.
Dare to dream Antibotter.
- Forums
- ASX - By Stock
- BTA
- holding up just fine compared to the rest!!!
holding up just fine compared to the rest!!!, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)